KC-2189

EMT6-PDL1 Cell Line

×
23562
Home » EMT6-PDL1 Cell Line

Background of EMT6-PDL1 Cell Line

CD274 encodes CD274 molecule and is also known as B7-H. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma. Alternative splicing results in multiple transcript variants.

Specifications

Catalog NumberKC-2189
Cell Line NameEMT6-PDL1 Cell Line
NCBI/UniProt Accession NumberNM_014143.4
Clone Number5#
Host Cell LineEMT6
DescriptionEMT6-PDL1 is a stable engineered cell line expressing human PDL1
QuantityOne vial of frozen cells (≥2×10⁶ cells/vial)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing Medium70% RPMI1640+20% FBS+10% DMSO
Propagation MediumRPMI1640+10%FBS+3μg/mL Puromycin
Selection MarkerPuromycin
MorphologyEpithelial
SubcultureSplit at a ratio of 1:4–1:6 every 2–3 days
Incubation37 °C with 5% CO₂
StorageLiquid nitrogen immediately upon receiving
Doubling TimeEstimated 19–36 hours
Mycoplasma StatusNegative
In Vivo ValidationNA

Cell Line Generation

EMT6-PDL1 cell line was generated using a lentiviral vector expressing the human PDL1 sequence.

Characterization

Figure 1: Characterization of human PDL1 overexpression in the EMT6-PDL1 stable clone using FACS.

Cell Resuscitation

  1. Pre-warm complete culture medium (basal medium and 10% FBS) in a 37°C water bath.
  2. Rapidly thaw the cryovial in a 37°C water bath for 1-2 minutes with gentle agitation.
  3. Transfer the vial to a biosafety cabinet, and disinfect the exterior with 70% ethanol.
  4. Aseptically transfer the cell suspension dropwise into a sterile centrifuge tube containing 9.0 mL of pre-warmed complete medium.
  5. Centrifuge at approximately 125 × g for 5–7 minutes at room temperature, carefully aspirate the supernatant without disturbing the cell pellet.
  6. Gently resuspend the pellet in an appropriate volume of complete medium and transfer the suspension into a T25 flask.
  7. Incubate the flask in a 37°C in a humidified 5% CO₂ incubator.
  8. Assess cell viability and morphology after 24 hours. If cells appear healthy, replace the medium with fresh medium supplemented with the appropriate selective antibiotic.
  9. Subculture the cells at a ratio of 1:4–1:6 every 2–3 days upon reaching 80%–90% confluency.

Cell Freezing

  1. Prepare the freezing medium (70% basal medium, 20% FBS and 10% DMSO) freshly before use.
  2. Pre-chill the freezing medium on ice and label the cryovials accordingly.
  3. Transfer the cell suspension to a sterile conical tube and perform a cell count to determine total viability and density.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature; carefully aspirate the supernatant.
  5. Gently resuspend the pellet in chilled freezing medium, ensuring a minimum cell density of 3×10⁶ cells/mL.
  6. Aliquot 1 mL of the cell suspension into each pre-labeled cryovial.
  7. Place the cryovials into a CoolCell® container and store at -80°C overnight for controlled-rate cooling.
  8. Transfer the cryovials to the liquid nitrogen for long-term storage the following day.

References

  1. Saraiva RP, Huizer TJ, Wijnhoven BPL et al. Concordance between tumor proportion score (TPS) and combined positive score (CPS) for PD-L1 expression in esophageal squamous cell carcinoma: a structured narrative review. Cancer treatment and research communications. 2026 Oct 17;49:101480. PMID: 42892302. doi: 10.1016/j.ctarc.2026.101480.
  2. Alswaiti Y, Shahwan G, Alhayek B et al. PD-1/ PD-l1 Inhibitors and Stereotactic Radiosurgery for Brain Metastases: a systematic review and meta-analysis. Clinical & experimental metastasis. 2026 Oct 17;43(6):. PMID: 42891757. doi: 10.1007/s10585-026-10439-5.
  3. Davidyuk DN, Samoylova SI, Demura TA et al. [Clinical and morphological characteristics and prognostic significance of the immune microenvironment and the level of PD-L1 expression in squamous cell carcinoma of the tongue and oropharynx]. Arkhiv patologii. 2026;88(5):81-86. PMID: 42885424. doi: 10.17116/patol20268805181.

Use License Agreement

Research Use Only.
Not for use in diagnostic procedures or therapeutic applications.
Redistribution of the cell line or its derivatives is prohibited without prior written permission from Kyinno Biotechnology.